Annual CFO:
$171.95M+$60.87M(+54.79%)Summary
- As of today, SUPN annual cash from operations is $171.95 million, with the most recent change of +$60.87 million (+54.79%) on December 31, 2024.
- During the last 3 years, SUPN annual cash from operations has risen by +$44.82 million (+35.26%).
- SUPN annual cash from operations is now at all-time high.
Performance
SUPN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$58.53M+$27.94M(+91.30%)Summary
- As of today, SUPN quarterly cash from operations is $58.53 million, with the most recent change of +$27.94 million (+91.30%) on June 30, 2025.
- Over the past year, SUPN quarterly cash from operations has increased by +$22.91 million (+64.31%).
- SUPN quarterly cash from operations is now -36.34% below its all-time high of $91.95 million, reached on June 30, 2020.
Performance
SUPN Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$187.06M+$22.91M(+13.96%)Summary
- As of today, SUPN TTM cash from operations is $187.06 million, with the most recent change of +$22.91 million (+13.96%) on June 30, 2025.
- Over the past year, SUPN TTM cash from operations has increased by +$32.20 million (+20.79%).
- SUPN TTM cash from operations is now at all-time high.
Performance
SUPN TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SUPN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +54.8% | +64.3% | +20.8% |
| 3Y3 Years | +35.3% | -17.7% | +55.8% |
| 5Y5 Years | +20.1% | -36.3% | +24.5% |
SUPN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +54.8% | at high | +410.1% | at high | +161.1% |
| 5Y | 5-Year | at high | +54.8% | -17.7% | +410.1% | at high | +161.1% |
| All-Time | All-Time | at high | +396.7% | -36.3% | +406.4% | at high | +389.3% |
SUPN Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $58.53M(+91.3%) | $187.06M(+14.0%) |
| Mar 2025 | - | $30.60M(-31.1%) | $164.15M(-4.5%) |
| Dec 2024 | $171.95M(+54.8%) | $44.41M(-17.0%) | $171.95M(-0.3%) |
| Sep 2024 | - | $53.52M(+50.2%) | $172.50M(+11.4%) |
| Jun 2024 | - | $35.62M(-7.2%) | $154.86M(+54.3%) |
| Mar 2024 | - | $38.40M(-14.6%) | $100.36M(-9.7%) |
| Dec 2023 | $111.08M(-4.9%) | $44.96M(+25.3%) | $111.08M(+18.6%) |
| Sep 2023 | - | $35.88M(+290.1%) | $93.69M(+30.7%) |
| Jun 2023 | - | -$18.87M(-138.4%) | $71.66M(-55.7%) |
| Mar 2023 | - | $49.13M(+78.2%) | $161.65M(+38.4%) |
| Dec 2022 | $116.83M(-8.1%) | $27.56M(+99.1%) | $116.83M(-15.4%) |
| Sep 2022 | - | $13.84M(-80.5%) | $138.03M(+14.9%) |
| Jun 2022 | - | $71.12M(+1553.2%) | $120.07M(+26.1%) |
| Mar 2022 | - | $4.30M(-91.2%) | $95.23M(-25.1%) |
| Dec 2021 | $127.13M(-8.1%) | $48.76M(+1286.4%) | $127.13M(+15.3%) |
| Sep 2021 | - | -$4.11M(-108.9%) | $110.30M(-8.1%) |
| Jun 2021 | - | $46.27M(+27.8%) | $120.01M(-27.6%) |
| Mar 2021 | - | $36.20M(+13.4%) | $165.68M(+19.7%) |
| Dec 2020 | $138.40M(-3.3%) | $31.93M(+470.3%) | $138.40M(-7.9%) |
| Sep 2020 | - | $5.60M(-93.9%) | $150.26M(-17.6%) |
| Jun 2020 | - | $91.95M(+931.3%) | $182.32M(+53.1%) |
| Mar 2020 | - | $8.92M(-79.6%) | $119.05M(-16.8%) |
| Dec 2019 | $143.13M(+11.0%) | $43.79M(+16.3%) | $143.13M(+8.3%) |
| Sep 2019 | - | $37.66M(+31.3%) | $132.19M(-15.8%) |
| Jun 2019 | - | $28.69M(-13.1%) | $156.98M(+16.4%) |
| Mar 2019 | - | $32.99M(+0.4%) | $134.85M(+4.5%) |
| Dec 2018 | $128.99M(+12.5%) | $32.85M(-47.4%) | $128.99M(-2.6%) |
| Sep 2018 | - | $62.45M(+852.5%) | $132.47M(+21.5%) |
| Jun 2018 | - | $6.56M(-75.8%) | $109.03M(-15.1%) |
| Mar 2018 | - | $27.13M(-25.3%) | $128.41M(+12.0%) |
| Dec 2017 | $114.64M | $36.34M(-6.8%) | $114.64M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $39.01M(+50.4%) | $103.24M(+11.6%) |
| Jun 2017 | - | $25.94M(+94.2%) | $92.48M(+11.0%) |
| Mar 2017 | - | $13.36M(-46.4%) | $83.31M(+24.7%) |
| Dec 2016 | $66.81M(+93.5%) | $24.94M(-11.7%) | $66.81M(+4.1%) |
| Sep 2016 | - | $28.24M(+68.3%) | $64.21M(+81.1%) |
| Jun 2016 | - | $16.78M(+634.0%) | $35.45M(+12.0%) |
| Mar 2016 | - | -$3.14M(-114.1%) | $31.65M(-8.3%) |
| Dec 2015 | $34.52M(+240.9%) | $22.34M(+4370.6%) | $34.52M(+80.0%) |
| Sep 2015 | - | -$523.00K(-104.0%) | $19.18M(-58.7%) |
| Jun 2015 | - | $12.98M(+4997.0%) | $46.49M(+75.0%) |
| Mar 2015 | - | -$265.00K(-103.8%) | $26.57M(+243.6%) |
| Dec 2014 | -$24.50M(+57.7%) | $6.99M(-73.9%) | $7.73M(+189.1%) |
| Sep 2014 | - | $26.78M(+485.9%) | -$8.68M(+83.0%) |
| Jun 2014 | - | -$6.94M(+63.7%) | -$51.02M(+14.7%) |
| Mar 2014 | - | -$19.10M(-102.8%) | -$59.83M(-3.2%) |
| Dec 2013 | -$57.95M(-22.8%) | -$9.42M(+39.4%) | -$57.95M(+10.4%) |
| Sep 2013 | - | -$15.55M(+1.3%) | -$64.67M(-7.0%) |
| Jun 2013 | - | -$15.76M(+8.5%) | -$60.42M(-11.2%) |
| Mar 2013 | - | -$17.22M(-6.7%) | -$54.35M(-15.2%) |
| Dec 2012 | -$47.20M(-30.4%) | -$16.14M(-42.8%) | -$47.20M(-20.0%) |
| Sep 2012 | - | -$11.30M(-16.6%) | -$39.32M(-5.9%) |
| Jun 2012 | - | -$9.69M(+3.8%) | -$37.12M(-1.8%) |
| Mar 2012 | - | -$10.07M(-21.9%) | -$36.45M(-0.7%) |
| Dec 2011 | -$36.19M(-11.2%) | -$8.26M(+9.3%) | -$36.19M(-29.6%) |
| Sep 2011 | - | -$9.10M(-0.9%) | -$27.93M(-48.4%) |
| Jun 2011 | - | -$9.02M(+7.9%) | -$18.82M(-92.1%) |
| Mar 2011 | - | -$9.80M | -$9.80M |
| Dec 2010 | -$32.54M(-1335.5%) | - | - |
| Dec 2009 | $2.63M(+108.9%) | - | - |
| Dec 2008 | -$29.65M(-112.1%) | - | - |
| Dec 2007 | -$13.98M | - | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Supernus Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of SUPN is $171.95M
What is the all-time high annual cash from operations for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual cash from operations is $171.95M
What is Supernus Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, SUPN annual cash from operations has changed by +$60.87M (+54.79%)
What is Supernus Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of SUPN is $58.53M
What is the all-time high quarterly cash from operations for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly cash from operations is $91.95M
What is Supernus Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, SUPN quarterly cash from operations has changed by +$22.91M (+64.31%)
What is Supernus Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of SUPN is $187.06M
What is the all-time high TTM cash from operations for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high TTM cash from operations is $187.06M
What is Supernus Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, SUPN TTM cash from operations has changed by +$32.20M (+20.79%)